Infectious Diseases Society Of America Guideline Update

Are current vaccination rates in the U.S. enough to bring an end to the pandemic? Keipp Talbot, MD, FIDSA of Vanderbilt University Medical Center and Amber Clayton of the Society for Human Resource Management join us to provide an update on COVID-19 vaccination and employer vaccine mandates.

How is the Delta variant impacting COVID-19 vaccine performance? Why are only certain populations being considered for boosters? Steven Pergam, MD, FIDSA of the Fred Hutchinson Cancer Research Center and Walter Orenstein, MD, FIDSA of Emory University answer these questions and more. *This episode was recorded on Oct. 5, 2021.

IDSA President-Elect Carlos del Rio, MD, FIDSA moderates a discussion with Lilian Abbo, MD, FIDSA, Angelica Cifuentes Kottkamp, MD, and Robert Rodriguez, MD on the impact the COVID-19 pandemic has had on the Latinx community, cultural nuances and practices for engaging in an effective and culturally competent patient-provider relationship and the progress made in developing pathways for the next generation of Hispanic physicians.

With children across the U.S. back in school, have mitigation strategies been effective in preventing the spread of COVID-19? Dr. Jason Newland of Washington University and Noelle Ng of the School Superintendents Association give an update on infection rates among children and share their thoughts on the Delta variant, mask mandates, and testing programs in schools.

In this episode, Dr. Ricardo Franco, Assistant Professor of Medicine at the University of Alabama at Birmingham, and Dr. Josh Barocas, Associate Professor of Medicine and Infectious Diseases Physician at the University of Colorado School of Medicine, examine the COVID-19 Delta variant surge, heated debates surrounding school masking guidelines, and how our nation and the world will achieve herd immunity.

In this episode moderator, Dr. David Weber, asks Dr. Marci Drees, Dr. Trini Mathew, and Dr. Sharon Wright questions surrounding the July 13th multi-society statement about COVID-19 vaccine as a condition of employment. Questions focus on how the societies developed this statement, why it was important to create this statement now, legal & human resources considerations, and more. (Rebroadcast of SHEA Podcast)

With schools set to re-open, the number of children COVID-19 hospitalizations on the rise, and vaccinations not yet authorized for children under age 12, what is the most important thing you can do to protect yourself and others? Dr. Preeti Malani, of the University of Michigan, and Dr. Tina Tan, of Northwestern University, weigh in on back-to-school and vaccination policies.

COVID-19: the race between the variants and the vaccinations. Do desperate times call for desperate measures? HIVMA Chair Rajesh Gandhi, MD, with Harvard University, and 2020 IDSA Society Citation Awardee Adarsh Bhimraj, MD, with the Cleveland Clinic, discuss COVID-19 treatments: the knowns, unknowns, and important factors in stemming the future of the pandemic.

Vaccination rates are inconsistent around the U.S. and globally. Is it safe to travel for summer vacations? Trish Perl, MD, FIDSA, of the University of Texas Southwestern Medical Center, and Preeti Malani, MD, FIDSA, of the University of Michigan, join us to discuss summer vacationing, travel, and how to be safe.

Is the “Fauci effect” enough to attract the number of doctors needed into the field of ID? In this episode, IDSA President Barbara Alexander, MD, FIDSA is joined by Wendy Armstrong, MD, FIDSA, of Emory University School of Medicine, and Michael Melia, MD, FIDSA, of Johns Hopkins School of Medicine, to discuss the current state of the ID Match and IDSA’s efforts to address recruitment into the field as well as its mentorship and professional development efforts.

In this episode, produced in partnership with the Mycoses Study Group Education and Research Consortium (MSGERC), we discuss Mucormycosis: the deadly fungal infection affecting COVID-19 patients in India with IDSA and MSGERC members, Ilan Schwartz, MD, PhD, Assistant Professor in the Division of Infectious Diseases at the University of Alberta, and Andrej Spec, MD, MS, Associate Director of the Infectious Diseases Clinical Research Unit, Director of the Invasive Mycoses Clinic, and Assistant Professor of Medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis.

The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to www.idsociety.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Stuart Johnson, M.D., Professor of Medicine, Loyola University Medical Center; Clinician Researcher, Departments of Research and Medicine, Edward Hines Jr. Veterans Administration Hospital

IDSA Board members Dr. Angela Caliendo, MD, PhD, FIDSA, Professor and Executive Vice Chair of Medicine at Alpert Medical School of Brown University, and Dr. Kimberly Hanson, MD, Professor at the University of Utah School of Medicine discuss Antigen Testing: What it is, what role testing will play from a screening perspective, and testing effectiveness.

In this episode, we discuss the CDC’s new masking guidance, the recommendations, surrounding challenges, and a return to the abnormal with IDSA Board Member and Fellow Dr. Jeanne Marrazzo, Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham, and Dr. Joshua Barocas, member of IDSA’s Public Health Committee and Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center.

IDSA members Krutika Kuppali, MD, of the Medical University of South Carolina, and Dawd Siraj, MD, of the University of Wisconsin-Madison, discuss the rapid rise in COVID-19 cases in India and whether the African continent will face a similar wave soon.

IDSA members Susan Kline, MD, of the University of Minnesota, Monica Gandhi, MD, of UC-San Francisco, and Jason Newland, MD, of Washington University, share thoughts about gatherings, mask protocol, and the trajectory of COVID-19 over the summer.

IDSA members Amesh Adalja, MD, of Johns Hopkins University, and Ali Mokdad, MD, of the Institute for Health Metrics and Evaluation, discuss the Covid-19 forecast for the months ahead and what we can do to prevent future surges in cases.

IDSA members Adarsh Bhimraj, MD, of the Cleveland Clinic, and Rajesh Gandhi, MD, of the Massachusetts General Hospital, discuss what we've learned about COVID-19 treatments as the pandemic has progressed.

IDSA members Anna Person, MD of Vanderbilt University and Kristin Englund, MD of the Cleveland Clinic discuss COVID-19 recovery and the special rehabilitation considerations and resources needed to treat patients.

IDSA President Barbara Alexander, MD, FIDSA sits down with IDSA/HIVMA member and CDC Director Rochelle P. Walensky, MD, MPH, FIDSA to talk about what it has been like to take over the helm of the nation’s top public health agency in the midst of a global pandemic and how her career in infectious diseases helped prepare her for this moment. The two also discuss Dr. Walensky’s priorities beyond the pandemic, her thoughts on the ID workforce and how IDSA, HIVMA and CDC might work together on common goals.